Related Experiment Video
Updated: Dec 10, 2025

06:17
Engineered 3D Silk-collagen-based Model of Polarized Neural Tissue
Published on: October 23, 2015
12.8K
Silk fibroin nanoscaffolds for neural tissue engineering
Rossana Boni1, Azam Ali2, Stephen G Giteru3
1Bioengineering Research Team, Centre for Bioengineering and Nanomedicine, Department of Food Science, University of Otago, PO Box 56, Dunedin, 9054, New Zealand.
Journal of Materials Science. Materials in Medicine
|August 29, 2020
Summary
This study developed novel three-dimensional nanoscaffolds (3DNSs) from silk fibroin, PEG, and PVA to promote nervous system repair. These nanoscaffolds showed potential in reducing reactive astrogliosis after stroke in mice.
Area of Science:
- Biomaterials Science
- Neural Engineering
- Regenerative Medicine
Background:
- Nervous system damage poses significant health risks due to limited regeneration capacity.
- Neural engineering seeks methods to stimulate repair in complex neural tissues.
- Developing biomaterials for central nervous system (CNS) regeneration is a critical challenge.
Purpose of the Study:
- To fabricate and characterize three-dimensional nanoscaffolds (3DNSs) for neural tissue regeneration.
- To evaluate the in vitro biological activity and in vivo effects of 3DNSs on reactive astrogliosis post-stroke.
- To investigate the influence of silk fibroin (SF) concentration on 3DNS properties and biological response.
Main Methods:
- Electrospinning of silk fibroin (SF), polyethylene glycol (PEG), and polyvinyl alcohol (PVA) to create 3DNSs.
- Characterization of 3DNS mechanical properties and internal structure based on SF concentration.
- In vitro assessment of 3DNSs using PC12 cells for viability.
- In vivo evaluation of 3DNSs in a photothrombotic stroke model in mice, assessing glial fibrillary acidic protein (GFAP) expression.
Main Results:
- SF concentration determined 3DNS morphology, yielding gel-like (SF ≥ 50%) or nanofibrous (SF ≤ 40%) structures.
- In vitro studies showed increased PC12 cell viability with 3DNSs.
- In vivo studies demonstrated a significant reduction in GFAP expression in the peri-infarct region, indicating suppressed reactive astrogliosis.
- The 3DNS formulations (F2 and F4) significantly impacted GFAP levels post-stroke.
Conclusions:
- The developed SF/PEG/PVA 3DNSs exhibit tunable mechanical and structural properties.
- 3DNSs promote neural cell viability in vitro and suppress reactive astrogliosis in vivo.
- These nanoscaffolds represent a promising therapeutic strategy for stroke recovery, potentially enhanced with drug or cell therapies.

